qlsyy.net (QLI) Short-Term Debt to Equity

qlsyy.net - graphic logo of issuer QLI

Qilian International (QLI) maintains a stable cash flow driven by traditional demand for plant extracts and licorice in the PRC. Strict government licensing and integration into regional supply chains create a high barrier to entry for the business. The price trend, where the indicator stands at 0.01, complements the profile of the Chinese generics manufacturer, which is investing in plant automation and the modernization of chemical synthesis.

Short-Term Debt to Equity Ratio: Qilian International Holding Group (QLI) for 07/04/2022 - 08/17/2024
Product sample of Qilian International Holding

This indicator measures the dependence of equity on short-term liabilities, allowing for an assessment of liquidity risk and the degree of shareholder protection against dilution. The current ratio of short-term loans to equity verifies the financial stability of Qilian International (QLI) during the large-scale implementation of robotic raw material extraction lines, confirming the company's ability to balance the debt financing of AI technologies with the preservation of fundamental solvency.

Key competitors

Short-Term Debt to Capital HLN|Short-Term Debt to Capital Kenvue Health (KVUE)|Short-Term Debt to Equity Verona Pharma plc VRNA|Ratio of Short-Term Indebtedness to Capital MENS|LGND - Short-Term Debt to Equity|Amneal Pharmaceuticals, Inc. (AMRX) - Short-Term Debt to Equity Ratio|PRGO: Short-Term Debt to Capital|Alvotech Biopharmaceuticals (ALVO) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio LQDA|GLPG: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity ANI Pharmaceuticals, Inc. (ANIP)|MNKD - Current Liabilities to Capital|Amphastar - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio PCRX (Pacira Corp)|ARS Pharmaceuticals - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital TBPH (theravance.com)|AQST: Short-Term Debt to Capital|Current Liabilities to Capital scPharmaceuticals (SCPH)|Short-Term Debt to Equity Tectonic Therapeutic Inc.|TNXP: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity China SXT Pharmaceuticals (SXTC)|eupraxiapharma.com (EPRX) - Short-Term Indebtedness to Equity|Short-Term Debt to Capital BHST (BioHarvest Sciences Inc.)|Short-Term Debt to Capital Coefficient Invizyne Technologies (EXOZ)|ORMP - Short-Term Debt to Equity|ENTX: Short-Term Debt to Equity|HYFT: Short-Term Debt to Capital|ABVC - Short-Term Debt to Capital Coefficient|CPIX (Cumberland Pharmaceuticals Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital Quantum BioPharma Ltd.|Short-Term Debt to Equity FibroGen Corp (FGEN)|Telomir Pharmaceuticals Corp - Short-Term Debt to Capital Ratio|Rani Therapeutics Holdings, Inc. - Short-Term Debt to Equity Ratio|Ratio of Short-Term Indebtedness to Capital SNYR|Rallybio Corp. - Short-Term Debt to Capital|Short-Term Debt to Capital Coefficient Lexaria Bioscience LEXX|Pulmatrix Corp (PULM) - Short-Term Debt to Equity|Short-Term Debt to Capital Ratio PTHL|Short-Term Debt to Equity Ratio APM|LYRA (lyratherapeutics.com) - Short-Term Loans to Capital Ratio|Short-Term Debt to Capital IBO|TNFA - Current Liabilities to Capital|Short-Term Debt to Equity cbdMD YCBD|Ratio of Short-Term Indebtedness to Capital PRFX|CYTO - Short-Term Debt to Equity|LIPO (lipella.com) - Short-Term Debt to Capital Ratio|OPTN: Short-Term Debt to Capital|Pieris Pharmaceuticals Inc (PIRS) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio PROC|PTPI (Petros Pharma) - Short-Term Loans to Capital Ratio|Short-Term Debt to Capital SLRN|Short-Term Debt to Capital Coefficient tffpharma.com